A letter from the editor

A letter from the editor

No public figure exists for Harvard’s investment in Allston since the 1980s: property purchases, planning consultants for the research campus envisioned a decade ago, design fees and construction for the halted science complex (about to be rebooted for engineering and applied sciences), permitting and community benefits for recent projects and their price tags, and financing for all of the above—totaling at least many hundreds of millions of dollars. Few if any other universities could have absorbed the cost.

One source of development funds was an annual half-percent “decapitalization” from the endowment put in place by President Neil L. Rudenstine in 2001, for five years, to pay for Allston infrastructure. President Lawrence H. Summers broadened its scope and extended its duration, to reconfigure the campuses old and new. From fiscal 2002 through 2013, that levy has yielded $1.523 billion. (The figure, now 10 percent of the annual endowment operating distribution, is no longer published, and the proceeds are considered a central administrative assessment, not an Allston line item per se.) Those revenues could have paid some of the up-front costs, and supported substantial construction debt.

But as reported in the last issue (page 31), the University has in the meantime incurred another Allston expense: from fiscal 2008 through last year, Harvard paid $1.255 billion to unwind interest-rate swap agreements it put in place in late 2004 to finance planned borrowing for fast-tracked construction. Money is fungible: dollar for dollar, the disbursements from the half-percent decapitalization may not have paid directly for undoing the swaps. But that money had to come from Harvard’s resources, and the facts remain: about $1.5 billion of endowment funds were disbursed; Harvard had to pay $1.255 billion to undo the swaps; effectively, very little of the sum released from the endowment has been available to defray costs to date for actual development in Allston (the original rationale for the assessment)—at a time when the endowment has declined in value, limiting academic budgets.

Recent changes in how administrators and the Corporation manage capital projects and finances should help avoid repeating such costly missteps, as planning for Allston’s future resumes (see page 18). So will Harvard’s new preference for donor and partner funding, instead of debt. More transparency would be desirable, too.

~John S. Rosenberg, Editor

Related topics

You might also like

Your Views on Harvard’s Standoff, Antisemitism, and More

Readers comment on the controversial July-August cover, authoritarianism, and scientific research.

Why Harvard Needs International Students

An ed school professor on why global challenges demand global experiences

Free Speech, the Bomb—and Donald Trump

A Harvard cardiologist on the unlikely alliances that shaped a global movement to prevent nuclear war

Most popular

What Trump Means for John Roberts’s Legacy

Executive power is on the docket at the Supreme Court.

Pablo Picasso Exhibit Opens at Harvard Art Museums

Harvard Art Museums exhibit on depictions of combat and revolution

This Harvard Scientist Is Changing the Future of Genetic Diseases

David Liu has pioneered breakthroughs in gene editing, creating new therapies that may lead to cures.

Explore More From Current Issue

A woman (Julia Child) struggles to carry a tall stack of books while approaching a building.

Highlights from Harvard’s Past

The rise of Cambridge cyclists, a lettuce boycott, and Julia Child’s cookbooks

A person walks across a street lined with historic buildings and a clock tower in the background.

Harvard In the News

A legal victory against Trump, hazing in the Harvard-Radcliffe Orchestra, and kicking off a Crimson football season with style

Illustration of tiny doctors working inside a large nose against a turquoise background.

A Flu Vaccine That Actually Works

Next-gen vaccines delivered directly to the site of infection are far more effective than existing shots.